Immunotherapy and prevention of autoimmune hepatitis
AssigneeImmunitor USA Inc.
InventorsAldar S. Bourinbaiar, Vichai Jirathitikal
Life of this patent
Estimating the term…
Abstract
The invention is within the field of immunology and microbiology, more specifically the field of virology and is related to immunotherapy and prophylaxis of hepatitis and autoimmune diseases. The composition useful for these purposes is disclosed, including the methods of making and using said composition.
Claims35
An oral composition comprising a therapeutically effective amount of a partially hydrolyzed antigen, wherein said partially hydrolyzed antigen is from a body fluid of a donor infected with a virus.
A method for treating a hepatitis, comprising administering to a subject in need thereof, an effective amount of an oral composition, said oral composition comprising a partially hydrolyzed hepatitis virus-infected cell, a hepatitis virus, or fragment thereof.
A vaccine for treatment or prevention of a microbial infection, said vaccine comprising a partially hydrolyzed microbial antigen and an alloantigen in a tablet or pill form.
A composition comprising an partially acid-hydrolyzed hepatitis antigen, an alloantigen, wherein said partially acid-hydrolyzed hepatitis antigen and alloantigen are embedded in a metal salt matrix.
A solid composition comprising an acid-hydrolyzed alloantigen embedded in an orally available metal salt matrix.
Dependencies are inferred from the claim text.